A comparison of the effects of a benzimidazole and the dinitroanilines against Leishmania infantum

Acta Tropica

Volumn 73, Issue 3, 1999, Pages 303-311

  Armson, A ^a   Kamau, S W ^b   Grimm, F ^b   Reynoldson, J A ^a   Best, W M ^c   MacDonald, L M ^a   Thompson, R C A ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Chemistry Centre Western Australia   (Australia)

Author keywords

Amastigotes; Benzimidazole; Dinitroaniline; Leishmania cidal; Leishmania infantum; Oryzalin; Promastigotes; Protozoa; Trifluralin; Tubulin

Indexed keywords

2,4 DINITROANILINE DERIVATIVE; 4 CHLORO 3,5 DINITROBENZOTRIFLUORIDE; ALBENDAZOLE; BENFLURALIN; BENZIMIDAZOLE DERIVATIVE; BETA TUBULIN; ORYZALIN; PENDIMETHALIN; TRIFLURALIN; TUBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFICACY; LEISHMANIA INFANTUM; LEISHMANIASIS; LIFE CYCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION;

ANILINE COMPOUNDS; ANIMALS; ANTIPROTOZOAL AGENTS; BENZIMIDAZOLES; DNA, PROTOZOAN; INHIBITORY CONCENTRATION 50; LEISHMANIA INFANTUM; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUBULIN;

ANIMALIA; LEISHMANIA INFANTUM; PROTOZOA;

EID: 0032701383     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(99)00034-0     Document Type: Article

References (32)

1. Arrowood M.J., Mead J.R., Xie L., You X. In vitro anticyrptosporidial activity of dinitroaniline herbicides. FEMS Microbiol. Lett. 136:1996;245-249.
2. Ashton F.M., Crafts A.S. Mode of Action of Herbicides. 1973;Wiley and Sons, Sydney.
3. Avila J.L., Avila A., Polegre M.E. Inhibitory effects of sinefungin and its cycling analog on the multiplication of Trypanasome cruzi isolates. Am. J. Trop. Med. Hyg. 48(1):1993;112-119.
4. Brun R., Kunz C. In vitro drug sensitivity test for Trypanosoma brucei subgroup bloodstream trypomastigotes. Acta Tropica. 46:1989;361-368.
5. Bryceson A.D.M., Chulay J.D., May H.O., Mugambii M., Were J.B., Muigai R., Chunge C., Gachihi G., Meme J., Anabwani G., Bhatt S.M. Visceral leishmaniasis unresponsive to antimonial drugs I. Clinical and immunological studies. Trans. R. Soc. Trop. Med. Hyg. 79:1985;700-704.
6. Callahan H.L., Kelley C., Pereira T., Grogl M. Microtubule inhibitors: structure-activity analyses suggest rational models to identify potentially active compounds. Antimicrob. Agents. Chemother. 40:1996;947-952.
7. Chan M.-Y., Grogl M., Chen C.-C., Bienen E.J., Fong D. Herbicides to curb human parasitic infections: in vitro and In vivo effects of trifluralin on the trypanosomatid protozoans. Proc. Natl. Acad. Sci. USA. 90:1993;5657-5661.
8. Chan M., Tzeng J., Emge T.J., Ho C.T., Fong D. Structure-function analysis of antimicrotubule dinitroanilines against promastigotes of the parasitic protozoan Leishmania mexicana. Antimicrob. Agents Chemother. 37:1993;1909-1913.
9. Chan M.M., Fong D. Plant microtubule inhibitors against Trypanosomatids. Parasit. Today. 10:1994;448-451.
10. Chan M.M., Triemer R.E., Fong D. Effect of the anti-microtubule drug oryzalin on growth and differentiation of the parasitic protozoan Leishmani mexicana. Differentiation. 46:1991;15-21.
11. Chiquero M.J., Perez-Victoria J.M., O'Valle F., Gonzalez-Ros J.M., del Moral R.G., Ferragut J.A., Castanys S., Gamarro F. Altered drug permeability in a multidrug-resistant Leishmania tropica line. Biochem. Pharmacol. 55:1998;131-139.
12. Cortés P., Cardeñosa N., Romani J., Gállego M., Muñoz C., Barrio J.L., Riera C., Portús M. Oral leishmaniasis in an HIV-positive patient caused by two different zymodemes of Leishmania infantum. Trans. R. Soc. Trop. Med. Hyg. 91:1997;438-439.
13. Davidson R.N., Croft S.L. Recent advances in the treatment of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 87:1993;130-131.
14. Dedet J.P., Lambert M., Pratlong F. Leishmaniose et infection par le virus de limmunodeficience humaine. Presse Medicale. 24:1993;1036-1040.
15. Eperon S., McMahon-Pratt D. Extracellular cultivation and morphological characterization of amastigote-like forms of Leishmania panamensis and L. braziliensis. J. Protozool. 36:1989;502-510.
16. Faraut-Gambarelli F., Piarroux R., Denian M., Giusiano B., Marty P., Micahel G., Faugere B., Dumon H. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob. Agents. Chemother. 41:1997;827-830.
17. Gasser R.A., Magill A.J., Oster C.N., Franke E.D., Grogl M., Berman J.D. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin. Infect. Dis. 18:1994;83-90.
18. Grimm F., Brun R., Jenni L. Promastigote infectivity in Leishmania infantum. Parasitol. Res. 77:1991;185-191.
19. Grogl M., Thomason T.N., Franke E.D. Drug resistance in Leishmania. Its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47:1992;117-126.
20. Hammoda N.A., Negm A.Y., Hussein E.D., el-Tamsahy M.M., Rashwan E.A. Leishmania major: leishmaniacidal activity of activated macrophages by interferon gamma or tumor necrosis factor. J. Egypt. Soc. Parasitol. 26(3):1996;555-566.
21. Handman E., Spira D.T. Growth of Leishmania amastigotes in macrophages in normal and immune mice. Zeitschrift. fur Parasitenkunde. 53(1):1977;75-81.
22. Herwaldt B.L., Neva F.A., Berman J.D. Allopurinal in the treatment of American cutaneous leishmaniasis. New. Engl. J. Med. 327(7):1992;498-499.
23. 50 in studies of drug resistance of malaria parasites. Acta. Tropica. 55:1996;257-261.
24. Katiyar S.K., Edlind T.D. tubulin genes of Trichomonas vaginalis. Mol. Biochem. Parasitol. 64:1994;33-42.
25. Katiyar S.K., Gordon V.R., McLaughlin G.L., Edlind T.D. Antiprotozoal activities of benzimidazoles and correlations with β-tubulin sequence. Antimicrob. Agents. Chemother. 38:1994;2086-2090.
26. Lubega G.W., Geary T.G., Klein R.D., Prichard R.K. Expression of cloned β-tubulin genes of Haemonchus contortus in Escherichia coli: interaction of recombinant β-tubulin with native tubulin and mebendazole. Mol. Biochem. Parasitol. 62:1993;281-292.
27. McHugh C.P., Melby P.C., LaFon S.G. Leishmaniasis in Texas: epidemiology and clinical aspects of human cases. Am. J. Trop. Med. Hyg. 55:1996;547-555.
28. Meloni B.P., Thompson R.C.A., Reynoldson J.A., Seville P. Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole. Trans. R. Soc. Trop. Med. Hyg. 84:1990;375-379.
29. Montalban C., Calleja J.L., Erice A., Laguna F., Clotet B., Podzamczer D., Cobo J., Mallolas J., Yebra M., Gallego A. The Co-operative Group for the Study of Leishmaniasis in AIDS. Visceral Leishmaniasis in patients infected with human immunodeficiency virus. J. Infect. 21:1990;261-270.
30. Pérez-Molina J.A., Fortun J., López-Vélez R. Anal ulcer and chronic diarrhoea as manifestations of visceral leishmaniasis in a patient infected with human immunodeficiency virus. Trans. R. Soc. Trop. Med. Hyg. 91:1997;436-437.
31. WHO, 1993. Global Health situation: IV. Selected infections and parasitic diseases due to identified organisms. Weekly Epidemiological Record. Geneva, WHO, 6; 41-48.
32. Woods K.M., Nesterenko M.V., Upton S.J. Efficacy of 101 antimicrobial agents on the development of Cryptosporidium parvum in vitro. Ann. Trop. Med. Parasit. 90:1996;601-615.